Cannon, R. E., Peart, J. C., Hawkins, B. T., Campos, C. R., & Miller, D. S. (2012). Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. National Academy of Sciences.

Cannon, Ronald E., John C. Peart, Brian T. Hawkins, Christopher R. Campos, a David S. Miller. Targeting Blood-brain Barrier Sphingolipid Signaling Reduces Basal P-glycoprotein Activity and Improves Drug Delivery to the Brain. National Academy of Sciences, 2012.

Cannon, Ronald E., et al. Targeting Blood-brain Barrier Sphingolipid Signaling Reduces Basal P-glycoprotein Activity and Improves Drug Delivery to the Brain. National Academy of Sciences, 2012.